These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26718093)

  • 1. The impact of RTOG 0614 and RTOG 0933 trials in routine clinical practice: The US Survey of Utilization of Memantine and IMRT planning for hippocampus sparing in patients receiving whole brain radiotherapy for brain metastases.
    Slade AN; Stanic S
    Contemp Clin Trials; 2016 Mar; 47():74-7. PubMed ID: 26718093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved plan quality with automated radiotherapy planning for whole brain with hippocampus sparing: a comparison to the RTOG 0933 trial.
    Krayenbuehl J; Di Martino M; Guckenberger M; Andratschke N
    Radiat Oncol; 2017 Oct; 12(1):161. PubMed ID: 28969706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality assurance analysis of hippocampal avoidance in a melanoma whole brain radiotherapy randomized trial shows good compliance.
    Martinage G; Hong AM; Fay M; Thachil T; Roos D; Williams N; Lo S; Fogarty G
    Radiat Oncol; 2018 Jul; 13(1):132. PubMed ID: 30029684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic Cranial Irradiation for Limited-Stage Small-Cell Lung Cancer: Survey of US Radiation Oncologists on Current Practice Patterns.
    Farrell MJ; Yahya JB; Degnin C; Chen Y; Holland JM; Henderson MA; Jaboin JJ; Harkenrider MM; Thomas CR; Mitin T
    Clin Lung Cancer; 2018 Jul; 19(4):371-376. PubMed ID: 29559208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001.
    Brown PD; Gondi V; Pugh S; Tome WA; Wefel JS; Armstrong TS; Bovi JA; Robinson C; Konski A; Khuntia D; Grosshans D; Benzinger TLS; Bruner D; Gilbert MR; Roberge D; Kundapur V; Devisetty K; Shah S; Usuki K; Anderson BM; Stea B; Yoon H; Li J; Laack NN; Kruser TJ; Chmura SJ; Shi W; Deshmukh S; Mehta MP; Kachnic LA;
    J Clin Oncol; 2020 Apr; 38(10):1019-1029. PubMed ID: 32058845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor Directed, Scalp Sparing Intensity Modulated Whole Brain Radiotherapy for Brain Metastases.
    Kao J; Darakchiev B; Conboy L; Ogurek S; Sharma N; Ren X; Pettit J
    Technol Cancer Res Treat; 2015 Oct; 14(5):547-55. PubMed ID: 24750002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment planning strategy for whole-brain radiotherapy with hippocampal sparing and simultaneous integrated boost for multiple brain metastases using intensity-modulated arc therapy.
    Pokhrel D; Sood S; McClinton C; Shen X; Lominska C; Saleh H; Badkul R; Jiang H; Mitchell M; Wang F
    Med Dosim; 2016 Winter; 41(4):315-322. PubMed ID: 27692518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-brain irradiation with hippocampal sparing and dose escalation on metastases: neurocognitive testing and biological imaging (HIPPORAD) - a phase II prospective randomized multicenter trial (NOA-14, ARO 2015-3, DKTK-ROG).
    Grosu AL; Frings L; Bentsalo I; Oehlke O; Brenner F; Bilger A; Fennell JT; Rothe T; Schneider-Fuchs S; Graf E; Schmoor C; Beck J; Becker G; Bock M; Egger K; Urbach H; Lahmann C; Popp I
    BMC Cancer; 2020 Jun; 20(1):532. PubMed ID: 32513138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing patient positioning for intensity modulated radiation therapy in hippocampal-sparing whole brain radiation therapy.
    Siglin J; Champ CE; Vakhnenko Y; Witek ME; Peng C; Zaorsky NG; Harrison AS; Shi W
    Pract Radiat Oncol; 2014; 4(6):378-83. PubMed ID: 25407858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of multi-criteria optimization (MCO) for volumetric modulated arc therapy (VMAT) in hippocampal avoidance whole brain radiation therapy (HA-WBRT).
    Zieminski S; Khandekar M; Wang Y
    J Appl Clin Med Phys; 2018 Mar; 19(2):184-190. PubMed ID: 29411526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-brain hippocampal sparing radiation therapy: Volume-modulated arc therapy vs intensity-modulated radiation therapy case study.
    Lee K; Lenards N; Holson J
    Med Dosim; 2016; 41(1):15-21. PubMed ID: 26235550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescription of memantine during non-stereotactic, brain-directed radiation among patients with brain metastases: a population-based study.
    Lamba N; Mehanna E; Kearney RB; Catalano PJ; Brown PD; Haas-Kogan DA; Aizer AA
    J Neurooncol; 2020 Jul; 148(3):509-517. PubMed ID: 32468331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric analysis of the alopecia preventing effect of hippocampus sparing whole brain radiation therapy.
    Mahadevan A; Sampson C; LaRosa S; Floyd SR; Wong ET; Uhlmann EJ; Sengupta S; Kasper EM
    Radiat Oncol; 2015 Nov; 10():245. PubMed ID: 26611656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hippocampal Sparing Whole Brain Radiotherapy and Integrated Simultaneous Boost vs Stereotactic Radiosurgery Boost: A Comparative Dosimetric Planning Study.
    Cheah SK; Matthews T; Teh BS
    Asian Pac J Cancer Prev; 2016; 17(9):4233-4235. PubMed ID: 27797223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetric evaluation of intensity-modulated radiotherapy, volumetric modulated arc therapy, and helical tomotherapy for hippocampal-avoidance whole brain radiotherapy.
    Rong Y; Evans J; Xu-Welliver M; Pickett C; Jia G; Chen Q; Zuo L
    PLoS One; 2015; 10(4):e0126222. PubMed ID: 25894615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric evaluation of four whole brain radiation therapy approaches with hippocampus and inner ear avoidance and simultaneous integrated boost for limited brain metastases.
    Jiang A; Sun W; Zhao F; Wu Z; Shang D; Yu Q; Wang S; Zhu J; Yang F; Yuan S
    Radiat Oncol; 2019 Mar; 14(1):46. PubMed ID: 30876444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the probability of underdosing microscopic brain metastases with hippocampal-sparing whole-brain radiation.
    Chang JS; Perez-Andujar A; Barani IJ; Ma L; Larson DA
    Radiother Oncol; 2016 Aug; 120(2):248-52. PubMed ID: 27406442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippocampal dosimetry correlates with the change in neurocognitive function after hippocampal sparing during whole brain radiotherapy: a prospective study.
    Tsai PF; Yang CC; Chuang CC; Huang TY; Wu YM; Pai PC; Tseng CK; Wu TH; Shen YL; Lin SY
    Radiat Oncol; 2015 Dec; 10():253. PubMed ID: 26654128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of hippocampus sparing during whole brain radiation therapy with simultaneous integrated boost-tutorial and efficacy of complete directional hippocampal blocking.
    Popp I; Grosu AL; Fennell JT; Fischer M; Baltas D; Wiehle R
    Strahlenther Onkol; 2022 Jun; 198(6):537-546. PubMed ID: 35357511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volumetric-modulated arc therapy (VMAT) for whole brain radiotherapy: not only for hippocampal sparing, but also for reduction of dose to organs at risk.
    Sood S; Pokhrel D; McClinton C; Lominska C; Badkul R; Jiang H; Wang F
    Med Dosim; 2017 Winter; 42(4):375-383. PubMed ID: 28822604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.